Income taxes (Details 1) - Exascale Labs Inc. [Member] - USD ($) |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|---|---|---|---|
| Deferred tax assets | |||
| Net operating loss carry forward | $ 1,652,998 | $ 748,679 | |
| Total deferred tax assets | 1,652,998 | 748,679 | |
| Less: valuation allowance | (1,652,998) | (748,679) | $ (200,468) |
| Total deferred tax assets, net |
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|